KRAS and non-small cell lung carcinoma: These comparisons showed that older age at diagnosis, smoking, dyslipidemia, hypertension, and family cancer history were more frequent in NSCLC than in CRC patients when KRAS mutations were present (P ≤ 0.04, Table 3).